Most European stock markets are moving in a positive direction on Thursday, with investors focusing on the scientific announcements for the new executive omicron in anticipation of the data that will be announced tomorrow in the US on inflation.
Global markets have rallied sharply in recent days as the scientific community’s initial estimates of the micron are reassuring, although health experts continue to advise caution as there is still much uncertainty. Initial data, however, show that the new executive is milder than the delta that has prevailed worldwide.
The announcements of Pfizer-BioNTech yesterday about the effectiveness of their vaccine against the new mutation were also encouraging. The two companies announced that based on the initial tests, the third dose of the vaccine is effective in treating the micron, while they stated that they will be able to have a new version of their vaccine by March 2022, adapted for the new mutation.
Investors, meanwhile, are waiting for the critical data to be announced on Friday in the US for the course of inflation after the jump of prices to a high of 30 years in October at 6.2%. The data will determine the next steps of the Federal Reserve, which may move earlier than expected to raise interest rates if it finds that high inflation shows no signs of slowing down.
On the board, the pan-European Stoxx 600 index gained 0.3% to 478.62 points.
The German DAX gained 0.2% to 15,717.07 points, the French CAC 40 gained 0.3% to 7,033.48 points, while the French FTSE 100 also strengthened 0.3% to 7,357.25 points.
In the periphery, the Italian FTSE MIB recorded marginal gains of 0.06%, while the Spanish IBEX 35 lost 0.5%.